コドン特異のKRAS変異の予後的な影響は,局所および進行段階の臓がんにおけるKRAS変異である
Sara Raji1, Hamed Zaribafzadeh1, Tyler Jones2
1Department of Surgery, Duke University School of Medicine, Durham, NC.
JCO precision oncology
|February 19, 2026
まとめ
臓がんにおける特定のKRAS変異は,疾患の段階によって患者の生存に異なる影響を及ぼします. この変動性を理解することは,KRAS阻害剤による治療の評価に極めて重要です.
科学分野:
- 腫瘍学 腫瘍学
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
背景:
- KRAS変異は,臓管腺がん (PDAC) の主要な要因である.
- 疾患の異なる段階における特定のKRASコドン変異の予後的な影響は十分に理解されていません.
- PDAC患者の詳細な臨床情報とゲノムプロフィールをリンクするデータは限られている.
研究 の 目的:
- コドン特異のKRAS変異とPDACにおける臨床遺伝学的特徴の関連性を調査する.
- これらの突然変異が,局所的および進行した疾患の段階の両方で患者のアウトカムに与える影響を決定する.
- 特定のKRAS変異に基づく全生存期 (OS) の差異を分析する.
主な方法:
- AACR GENIEバイオファーマコンソーシアム パンクレア v1.2 データセットを使用しました.
- コドン特異のKRAS変異を中心にPDACを患った1,032人の適格な患者を分析した.
- カプラン・マイヤーとコックスの比例リスクモデルを用いた全生存率の比較.
主要な成果:
- 患者の92%が突然変異のKRASを有しており,G12D,G12V,G12Rが最も一般的であった.
- 局所的なPDACでは,KRAS G12VはG12D (P=.03) よりも長生きを示した.
- 先進的なPDACでは,KRAS G12VはG12RとG12DよりもOSが短かった (P=.04の両方).
- KRAS変異の間で共同変異のドライバー遺伝子 (TP53,CDKN2A,SMAD4) の有意な差異は見つかりませんでした.
結論:
- コドン特異のKRAS変異は,疾患のステージに基づいてPDACのアウトカムに差異的な効果を持っています.
- KRAS変異の予測的変動性は,正確な治療効果評価のために考慮する必要があります.
- これは,KRAS阻害剤の臨床試験において,特定のKRAS変異によって患者を階層化することの重要性を強調しています.
さらに関連する動画
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.8K
06:57Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
Published on: April 7, 2018
11.5K
関連する概念動画
02:38The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
01:33Cancer-Critical Genes I: Proto-oncogenes
11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K